GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » Earnings per Share (Diluted)

Nidan Laboratories and Healthcare (NSE:NIDAN) Earnings per Share (Diluted) : ₹2.55 (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nidan Laboratories and Healthcare Earnings per Share (Diluted)?

Nidan Laboratories and Healthcare's Earnings per Share (Diluted) for the six months ended in Mar. 2024 was ₹0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2.55.

Nidan Laboratories and Healthcare's EPS (Basic) for the six months ended in Mar. 2024 was ₹0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2.55.

Nidan Laboratories and Healthcare's EPS without NRI for the six months ended in Mar. 2024 was ₹0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2.55.


Nidan Laboratories and Healthcare Earnings per Share (Diluted) Historical Data

The historical data trend for Nidan Laboratories and Healthcare's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nidan Laboratories and Healthcare Earnings per Share (Diluted) Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Earnings per Share (Diluted)
Get a 7-Day Free Trial 0.51 1.66 2.32 2.55 -2.33

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial 1.30 1.02 1.67 0.88 -

Competitive Comparison of Nidan Laboratories and Healthcare's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nidan Laboratories and Healthcare's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's PE Ratio distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's PE Ratio falls into.


;
;

Nidan Laboratories and Healthcare Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Nidan Laboratories and Healthcare's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (A: Mar. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-32.323-0)/13.900
=-2.33

Nidan Laboratories and Healthcare's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0-0)/13.900
=0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Nidan Laboratories and Healthcare  (NSE:NIDAN) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Nidan Laboratories and Healthcare Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Nidan Laboratories and Healthcare's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Nidan Laboratories and Healthcare Business Description

Traded in Other Exchanges
N/A
Address
Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.

Nidan Laboratories and Healthcare Headlines

No Headlines